This report describes a multi-receptor physiological model of the fMRI temporal response and signal magnitude 23 evoked by drugs that elevate synaptic dopamine in basal ganglia. The model is formulated as a summation of do-24 pamine's effects at D1-like and D2-like receptor families, which produce functional excitation and inhibition, re-25 spectively, as measured by molecular indicators like adenylate cyclase or neuroimaging techniques like fMRI.
Normandin This report describes a multi-receptor physiological model of the fMRI temporal response and signal magnitude 23 evoked by drugs that elevate synaptic dopamine in basal ganglia. The model is formulated as a summation of do-24 pamine's effects at D1-like and D2-like receptor families, which produce functional excitation and inhibition, re-25 spectively, as measured by molecular indicators like adenylate cyclase or neuroimaging techniques like fMRI.
26 Functional effects within the model are described in terms of relative changes in receptor occupancies scaled 27 by receptor densities and neuro-vascular coupling constants. Using literature parameters, the model reconciles 28 many discrepant observations and interpretations of pre-clinical data. Additionally, we present data showing 29 that amphetamine stimulation produces fMRI inhibition at low doses and a biphasic response at higher doses 30 in the basal ganglia of non-human primates (NHP), in agreement with model predictions based upon the respec-31 tive levels of evoked dopamine. Because information about dopamine release is required to inform the fMRI 32 model, we simultaneously acquired PET produce opposing effects on the production of cyclic-AMP through acti-54 vation or inhibition of adenylate cyclase (Neves et al., 2002; Stoof and 55 Kebabian, 1981) . The G-protein coupled D1 and D2 signaling pathways 56 affect a host of functions, including regulation of metabolic enzymes, 57 ion channels, and plasticity through gene transcription (Carlezon et al., 58 2005; Neves et al., 2002) . Although the complexity of these cellular sig-59 naling pathways makes it difficult to define a precise mechanistic rela- 
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The model becomes more intuitive if we replace the absolute con- and D2-like receptors producing inhibition. Fig. 1 illustrates the two-216 receptor model, which is defined by these equations: which are estimates from the literature.
234
Receptor densities (B max ) have been measured in rats and NHP by 235 autoradiography, and PET also can estimate densities in vivo through 236 binding potentials. Although there are variations in receptor densities re-237 gionally and across studies, the overall ratio of D1 to D2 receptors is 238 slightly larger than unity in the basal ganglia of wild-type mice 239 (Thompson et al., 2010) , NHP (Madras et al., 1988; Weed et al., 1998), 240 and humans (Hall et al., 1994; Piggott et al., 1999) . However, docile 241 mice possess a high D1 to D2 receptor ratio in comparison with an ag-242 gressive strain (Couppis et al., 2008) , suggesting that selective breeding 243 for passivity can alter this ratio in laboratory rodents. In fact, laboratory 244 rats possess a D1 to D2 receptor ratio in striatum of nearly 3 (Hyttel 245 and Arnt, 1987; Schoffelmeer et al., 1994; Seeman, 1987) . Weed et al. 246 (1998) provided particularly good data on this subject by employing 247 multiple concentrations of multiple ligands to measure D1 and D2 recep-248 tor densities in both rats and NHP; they concluded that macaque stria- Table 1 are consistent with these data.
255
Basal D2 occupancy has been measured in human studies using , 1997a; Martinez et al., 2009; Verhoeff et al., 2001 Verhoeff et al., , 2002 (Schoffelmeer et al., 1994) . Conversely, two reports 294 found similar D1 and D2 binding affinities for DA (Madras et al., 1988; 295 Sokoloff et al., 1992), although the latter study also reported high 0.5 and 1 min
affinities for D3 and D5 relative to either D1 or D2 receptors. We as-
297
sumed an affinity ratio of 4 in favor of the D2-family of receptors rela-298 tive to the D1 family, based upon inhibition constants for human 299 receptors (Marcellino et al., 2011) . However, this affinity ratio is not 300 well constrained by available data.
301
In addition to the fixed quantities in Table 1, Animal Care at Massachusetts General Hospital.
335
Functional MRI employed the IRON method (Mandeville, 2012) 
and peak levels of DA release can be estimated by setting the derivative 387 to zero to obtain
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Maximum changes in DA levels can be related to relative changes 391 in DBP ND (Eq. (10)) using curves to approximately match data prior to amphetamine injection.
405
Simulations were analyzed using the DBP ND metric, and these were 
were converted to changes in the delivery (K1) and washout (k2) Simulations in Fig. 2 employ the parameter set shown in Table 1 , to-
431
gether with a function for DA release defined by the red curve in Fig. 2a 432 (Bradberry, 2000) , in order to provide model predictions corresponding
433
to a cocaine dose of about 0.5 mg/kg in the laboratory rat versus NHP.
434
Note that the basal occupancy by DA at D2 receptors is about 3-fold
435
higher than the D1 occupancy in the model as a consequence of the pre-
436
sumed ratio of affinities (Eq. (9)). Accordingly, the higher affinity of DA 
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For NHP, which has similar D1 and D2 densities, the negative model re-
446
sponse matches fMRI data in this species (Mandeville et al., 2011) . In the measured response using an amphetamine dose of 0.6 mg/kg clearly 494 was negative in NHP striatum (Fig. 4a) . At a dose of 1 mg/kg amphet-495 amine, a biphasic shape described the CBV data best, with a rapid and pro-496 nounced initial decrease followed by an overshoot that resolved slowly 497 toward baseline.
498
Simulations provided a good description of these data. In analysis, 499 simulations provided model shapes (red curves) that were used as 
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Amphetamine produced large and prolonged increases in blood that perhaps is most constrained by the literature is the D1/D2 receptor 532 ratio (Fig. 4a) , which is 1.2 to 1.4 in two studies using autoradiography 533 in NHP (Madras et al., 1988; Weed et al., 1998) and about unity in 534 human postmortem caudate and putamen (Hall et al., 1994; Piggott et 535 al., 1999) . Given the similar densities of D1 and D2 receptors, the model Fig. 4 . Simulations were performed for two doses of amphetamine (0.6 and 1 mg/kg) that were assumed to increase synaptic dopamine 10-fold and 20-fold (blue curves), respectively. Simulation results for fMRI signal were employed as GLM analysis regressors (red curves) to describe data from whole putamen (black points) with a single scaling factor after correction for baseline drift using a quadratic polynomial. The functional map from one session (M3, 1 mg/kg) shows voxels that were significantly correlated with the regressor and exhibited maximal changes in CBV greater than 5%. Fig. 3 . Scenarios in which the predicted fMRI response closely reflects the temporal evolution of evoked dopamine (DA). a) High levels of evoked DA in the rat cause D1 effects to dominate, so that fMRI signal matches DA in time, in agreement with empirical data using amphetamine infusion in rats (Chen et al., 1999) . b) Low levels of evoked DA, as would be expected using about 0.25 mg/kg cocaine, cause D2 effects to dominate in NHP; note that the fMRI sign has been reversed in NHP for comparison with DA.
Simulations show the effect of varying individual parameters in Table 1 , assuming the dopamine release function in Fig. 2a . Parameter choices are discussed in the text. Note that the fMRI model cannot reproduce data in NHP for cocaine infusion (Mandeville et al., 2011) or amphetamine administration (Fig. 4) unless dopamine affinity is strongly biased in favor of D2 relative to D1 receptors. Table 1 , including a D2 basal occupancy of 25% and an affinity ratio of 4. Dashed lines use a D2 basal occupancy of 40% and an affinity ratio of 10.
cannot reproduce measured NHP or mouse fMRI data with any combina-537 tion of parameters unless DA affinities are strongly biased toward D2 recep-538 tors (Fig. 5c) . Conversely, variation of D2 basal occupancy (Fig. 5d) of changes in D2 occupancy by defining the rate of receptor saturation.
556
Hence, the model can produce almost redundant solutions by covarying 557 D2 basal occupancy and affinity, so that one value is needed in order to 558 fix the other.
559
PET correlates of DA release
560
In two studies, corresponding to the two panels of Fig. 4 labeled as 561 monkey M2, we acquired PET data in conjunction with fMRI (Fig. 7) . In 
568
For the injected dose 0.6 mg/kg amphetamine (Fig. 7a) , DBP ND
569
(Eq. (10), thick red curve) was suppressed by a maximum of 65-70% 570 in putamen, depending upon the size of the region of interest, at the 571 end of data collection. This corresponds to about a 9-fold increase in 572 DA, which is similar to peak levels from the microdialysis literature.
573
However, the response was slow and protracted compared to the anal- Similar results were obtained using the higher dose of 1 mg/kg 579 (Fig. 7b) . Raclopride binding in putamen was suppressed by a maxi-580 mum value of 55-60% by the end of the scan, corresponding to an es-581 timated 6-fold increase in DA, and the optimal sigmoidal time 582 constant was 85 min. Again, these changes in raclopride binding 583 were blunted and occurred much more slowly than suggested by 584 classical-model simulations based upon the microdialysis literature.
585
To ensure that measured changes in time-activity curves were specific 586 to binding, rather than delivery and washout, we performed forward- Risinger et al., 2005; Wilson et al., 2004) , and NHP models 617 also report frontal activation associated with conditioned cocaine visual 
stimuli in the absence of drug delivery (Nelissen et al., 2012 in Eqs. (7) and (11)) but with different sources of error, combined mea-739 surements should offer a better estimation of neurotransmitter release.
740
In this study, very high levels of evoked DA provided a means to test the 
